$203.382,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

In collaboration with Consulting Editor, Dr. Charles J. Lightdale, Guest Editor Dr. Sachin Wani has put together a state-of-the art issue that presents the latest advances in Barrett’s Esophagus. He has secured expert authors who have contributed clinical reviews on the following topics: The epidemiology of Barrett’s esophagus and esophageal adenocarcinoma – implications for screening and surveillance; Endoscopic screening for Barrett’s esophagus and esophageal adenocarcinoma: rationale, candidates and challenges; Progress in screening for Barrett’s esophagus: beyond standard upper endoscopy; Best practices in surveillance for Barrett’s esophagus; Pathologic assessment of Barrett’s esophagus and Barrett’s related neoplasia: Do we need quality indicators; Cost effectiveness of screening, surveillance and endoscopic eradication therapies in Barrett’s esophagus and early esophageal cancer; Advanced imaging and sampling in Barrett’s esophagus: Artificial intelligence to the rescue; Advances in biomarkers for risk stratification in Barrett’s esophagus; Current status of chemoprevention in Barrett’s esophagus; Optimizing outcomes with radiofrequency frequency ablation of Barrett’s esophagus: candidates, efficacy and durability; Updates in cryotherapy for Barrett’s esophagus; Role of endoscopic mucosal resection and endoscopic submucosal dissection in the management of Barrett’s related neoplasia; Practical approach to refractory and recurrent Barrett’s esophagus; Surgical management of Barrett’s related neoplasia; and Measuring Quality in Barrett’s esophagus: Time to embrace quality indicators. Endoscopists will come away with the information they need to screen, diagnose, and treat patients with Barrett’s Esophagus.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xv 9. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance - p. 1 10. Endoscopic Screening for Barrett’s Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges - p. 27 11. Progress in Screening for Barrett’s Esophagus: Beyond Standard Upper Endoscopy - p. 43 12. Best Practices in Surveillance for Barrett's Esophagus - p. 59 13. Cost-Effectiveness of Screening, Surveillance, and Endoscopic Eradication Therapies for Managing the Burden of Esophageal Adenocarcinoma - p. 77 14. Advanced Imaging and Sampling in Barrett’s Esophagus: Artificial Intelligence to the Rescue? - p. 91 15. Advances in Biomarkers for Risk Stratification in Barrett’s Esophagus - p. 105 16. Current Status of Chemoprevention in Barrett’s Esophagus - p. 117 17. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability - p. 131 18. Updates in Cryotherapy for Barrett’s Esophagus - p. 155 19. Role of Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection in the Management of Barrett’s Related Neoplasia - p. 171 20. A Practical Approach to Refractory and Recurrent Barrett's Esophagus - p. 183 21. Surgical Management of Barrett’s-Related Neoplasia - p. 205 22. Measuring Quality in Barrett’s Esophagus: Time to Embrace Quality Indicators - p. 219

Descripcion
Descripción

In collaboration with Consulting Editor, Dr. Charles J. Lightdale, Guest Editor Dr. Sachin Wani has put together a state-of-the art issue that presents the latest advances in Barrett’s Esophagus. He has secured expert authors who have contributed clinical reviews on the following topics: The epidemiology of Barrett’s esophagus and esophageal adenocarcinoma – implications for screening and surveillance; Endoscopic screening for Barrett’s esophagus and esophageal adenocarcinoma: rationale, candidates and challenges; Progress in screening for Barrett’s esophagus: beyond standard upper endoscopy; Best practices in surveillance for Barrett’s esophagus; Pathologic assessment of Barrett’s esophagus and Barrett’s related neoplasia: Do we need quality indicators; Cost effectiveness of screening, surveillance and endoscopic eradication therapies in Barrett’s esophagus and early esophageal cancer; Advanced imaging and sampling in Barrett’s esophagus: Artificial intelligence to the rescue; Advances in biomarkers for risk stratification in Barrett’s esophagus; Current status of chemoprevention in Barrett’s esophagus; Optimizing outcomes with radiofrequency frequency ablation of Barrett’s esophagus: candidates, efficacy and durability; Updates in cryotherapy for Barrett’s esophagus; Role of endoscopic mucosal resection and endoscopic submucosal dissection in the management of Barrett’s related neoplasia; Practical approach to refractory and recurrent Barrett’s esophagus; Surgical management of Barrett’s related neoplasia; and Measuring Quality in Barrett’s esophagus: Time to embrace quality indicators. Endoscopists will come away with the information they need to screen, diagnose, and treat patients with Barrett’s Esophagus.

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Foreword - p. xiii 8. Preface - p. xv 9. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance - p. 1 10. Endoscopic Screening for Barrett’s Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges - p. 27 11. Progress in Screening for Barrett’s Esophagus: Beyond Standard Upper Endoscopy - p. 43 12. Best Practices in Surveillance for Barrett's Esophagus - p. 59 13. Cost-Effectiveness of Screening, Surveillance, and Endoscopic Eradication Therapies for Managing the Burden of Esophageal Adenocarcinoma - p. 77 14. Advanced Imaging and Sampling in Barrett’s Esophagus: Artificial Intelligence to the Rescue? - p. 91 15. Advances in Biomarkers for Risk Stratification in Barrett’s Esophagus - p. 105 16. Current Status of Chemoprevention in Barrett’s Esophagus - p. 117 17. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability - p. 131 18. Updates in Cryotherapy for Barrett’s Esophagus - p. 155 19. Role of Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection in the Management of Barrett’s Related Neoplasia - p. 171 20. A Practical Approach to Refractory and Recurrent Barrett's Esophagus - p. 183 21. Surgical Management of Barrett’s-Related Neoplasia - p. 205 22. Measuring Quality in Barrett’s Esophagus: Time to Embrace Quality Indicators - p. 219

Indice
Autores
Muestra
Ficha Técnica